Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Coronavirus impact | Future Group's Kishore Biyani in a difficult situation as lenders invoke shares: Report

Stocks of Future Group's listed entities plunged over the past month, due to fears over the outbreak's economic impact.

March 25, 2020 / 11:31 AM IST
Kishore Biyani

Kishore Biyani

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Future Group chief executive officer (CEO) Kishore Biyani is in a difficult situation as lenders have sought more collateral against his pledged shares, according to a Mint report.

The coronavirus, or COVID-19 outbreak, has impacted Future Group's business. The company had signed deals with Amazon, Blackstone, and Nippon group over the past six months.

Stocks of the group's listed entities plunged over the past month, due to fears over the outbreak's economic impact. Future Enterprises, Future Lifestyle Fashions, Future Retail, and Future Supply Chain Solutions have lost around half of their value since the start of 2020.

On March 24, Future Retail said some lenders who held non-convertible debentures (NCDs) through IDBI Trusteeship Services invoked pledged shares worth 8 percent.

Future Group is evaluating several ways to solve the debt problem, said the report. One such method is selling the entire business of Future Lifestyle Fashions.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Future group is also exploring the option of fundraising at the promoter level, through a combination of equity and structured debt, the report said.

“The promoters are engaged in talks with various investors to raise money. They would need an infusion of around Rs 1,000-1,500 crore in the near term," a source told the publication.

Moneycontrol could not independently verify the report.

Moneycontrol News
first published: Mar 25, 2020 11:31 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347